Quinolone Resistance in Helicobacter pylori Isolates in Germany-Reference-Cited by-同舟云学术

Quinolone Resistance in Helicobacter pylori Isolates in Germany

Published:2007-01 Issue:1 Volume:51 Page:346-349
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Glocker Erik¹,Stueger Hans-Peter²,Kist Manfred¹

Affiliation:

1. Department of Microbiology and Hygiene, Institute of Medical Microbiology and Hygiene, University Hospital Freiburg, Hermann-Herder-Str. 11, 79104 Freiburg, Germany

2. Institute of Biostatistics, Austrian Agency for Health and Food Safety, Graz, Austria

Abstract

ABSTRACT We show that quinolone resistance in Helicobacter pylori has reached an alarming level in Germany. Our data suggest that the use of quinolones requires prior antimicrobial susceptibility testing, especially for isolates from patients who have already undergone previous unsuccessful eradication treatments, and also underline the further need for surveillance studies to monitor antibiotic resistance in H. pylori .

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00614-06

Reference26 articles.

1. Helicobacter pylori Uptake and Efflux: Basis for Intrinsic Susceptibility to Antibiotics In Vitro

2. Branca, G., T. Spanu, G. Cammarota, A. M. Schito, A. Gasbarrini, G. B. Gasbarrini, and G. Fadda. 2004. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. Int. J. Antimicrob. Agents24:433-438.

3. Cabrita, J., M. Oleastro, R. Matos, A. Manhente, J. Cabral, R. Barros, A. I. Lopes, P. Ramalho, B. C. Neves, and A. S. Gurreiro. 2000. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). J. Antimicrob. Chemother.46:1029-1031.

4. Cammarota, G., R. Cianci, O. Cannizzaro, L. Cuoco, G. Pirozzi, A. Gasbarrini, A. Armuzzi, M. A. Zocco, L. Santarelli, F. Arancio, and G. Gasbarrini. 2000. Efficacy of two one-week rabeprazol/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment. Pharmacol. Ther.14:1339-1343.

5. Carratala, J., A. Fernandez-Sevilla, F. Tubau, F. Manresa, and F. Gudiol. 2004. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob. Agents Chemother.40:503-505.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic Resistance of Helicobacter pylori in Patients with Peptic Ulcer;Medicina;2022-12-20

2. Green and one-pot synthesis of novel amidoalkyl naphthols using triethanolammonium acetate [(OHCH2CH2)3NH][OAc]) ionic liquid and their anti-H.pylori activity;Research on Chemical Intermediates;2022-08-19

3. Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies;Molecules;2021-10-08

4. Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients;Archives of Medical Research;2021-07

5. Antimicrobial Resistance of Helicobacter pylori in Gastric Biopsy Samples from Lima/Peru;Microbial Drug Resistance;2021-07-01